European Generics Industry Flags Up 'Duplication' And 'Redundancies' In EU Regulatory Systems
This article was originally published in The Pink Sheet Daily
Executive Summary
Trade group also wants generic companies to be able to use EU's centralized authorization process even if the reference product didn't.